Efficacy of Treatment for Somatoform Disorders: A Review of Randomized Controlled Trials
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To review the evidence from randomized clinical trials (RCTs) that have focused on the treatment of patients with Diagnostic and Statistical Manual of Mental Disorders, 4(th) Edition (DSM-IV) somatoform disorders. Although somatoform disorders are among the most common mental disorders presenting in the general medical setting, the strength of evidence for specific treatments has not been well synthesized. METHODS: MEDLINE search of articles published in English from 1966 to 2006, using the following search terms: randomized clinical trial, somatoform disorders, somatization disorder, undifferentiated somatoform disorder, hypochrondriasis, conversion disorder, pain disorder, and body dysmorphic disorder. RESULTS: A total of 34 RCTs involving 3922 patients were included. Two thirds of the studies involved somatization disorder (n = 4 studies) and lower threshold variants, such as abridged somatization disorder (n = 9) and medically unexplained symptoms (n = 10). Cognitive behavioral therapy (CBT) was effective in most studies (11 of 13), as were antidepressants in a small number (4 of 5) of studies. RCTs examining a variety of other treatments showed benefit in half (8 of 16) of the studies, the most consistent evidence existing for a consultation letter to the primary care physician. Effective treatments have been established for all somatoform disorders except conversion disorder (1 of 3 studies showing benefit) and pain disorder (no studies reported). CONCLUSION: CBT is the best established treatment for a variety of somatoform disorders, with some benefit also demonstrated for a consultation letter to the primary care physician. Preliminary but not yet conclusive evidence exists for antidepressants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00008 · Cited by 3,298
Self-citationUtility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.272.22.1749 · Cited by 2,635
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401 · cited 1×
“8 or greater are considered large therapeutic effects (61).”
BackgroundUtility of a New Procedure for Diagnosing Mental Disorders in Primary Care: The PRIME-MD 1000 Study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.1994.03520220043029 · Cited by 1,873
Summing up: The Science of Reviewing Research
Wilkinson, I., Light, R. J., & Pillemer, D. B. (1987) · Journal of Educational Statistics · doi:10.2307/1164691 · Cited by 1,471
Summing Up: The Science of Reviewing Research
Light, R. J., & Pillemer, D. B. (1984) · Harvard University Press eBooks · doi:10.4159/9780674040243 · Cited by 1,427
Barsky, A. J., Orav, E. J., & Bates, D. W. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.8.903 · Cited by 911
Medically Unexplained Physical Symptoms, Anxiety, and Depression: A Meta-Analytic Review
Henningsen, P., Zimmermann, T., & Sattel, H. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000075977.90337.e7 · Cited by 829
Ormel, E. A. (1995) · PsycEXTRA Dataset · doi:10.1037/e536912011-072 · Cited by 706
Cited by
Items 201–300 of 449
Functional Neurological Disorder: Historical Trends and Urgent Directions
Velazquez-Rodriguez, Y., & Fehily, B. (2023) · Journal of Neurology Research · doi:10.14740/jnr754 · Cited by 14
Magallón-Botaya, R. M., Gili, M., Moreno, S., Bauzá, N., García‐Campayo, J., Roca, M., Ruiz, Y., & Andres, E. M. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-47 · Cited by 14
“According to these studies, antidepressant drugs (tricyclic antidepressants, mirtazapine, venlafaxine and duloxetine) [13,14] achieved a significative improvement in these disorders.”
BackgroundCarlier, I. V. E., Wiltens, D. H. A., van Rood, Y. R., van Veen, T., Dekker, J., & van Hemert, A. M. (2018) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2191 · Cited by 12
“Our modest treatment results for somatoform disorders are in line with studies in primary care (e.g., Steinbrecher & Hiller, 2011) and secondary care (e.g., Zonneveld et al., 2012; Deary et al, 2007), but in contrast with those that found somewhat better treatment results (e.g., Kroenke, 2007).”
ResultSingh, S. M., Prakash, V., Choudhary, S., & Avasthi, A. (2018) · Cureus · doi:10.7759/cureus.2729 · Cited by 10
Wortman, M. S. H., van der Wouden, J. C., Grutters, J. P. C., Visser, B., Assendelft, W. J., van der Horst, H. E., & Hartman, T. O. (2019) · Trials · doi:10.1186/s13063-019-3913-3 · Cited by 13
Narcissism Predicts Therapy Outcome in Psychosomatic Patients
Daig, I., Klapp, B. F., & Fliege, H. (2009) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-008-9122-0 · Cited by 15
“A meta-analytic study comprising 34 randomized controlled studies showed that cognitive behavioural therapy was effective in most studies (11 of 13) treating somatization, as were antidepressants in a small number (4 of 5) of studies ( Kroenke 2007 ).”
MethodMedically unexplained visual loss in adult patients
Griffiths, P. G., & Ali, N. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32831db29c · Cited by 13
Sumathipala, A. (2013) · International Journal of Social Psychiatry · doi:10.1177/0020764012467897 · Cited by 11
“There is more Level I (systematic reviews) evidence for CBT than for other approaches (Kroenke, 2007; Sumathipala, 2007).”
BackgroundLeary, P. M. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52910-7.00010-6 · Cited by 10
Approach to the patient with multiple somatic symptoms
Nair, S., Kwan, S., Ng, C., & Teo, D. (2021) · Singapore Medical Journal · doi:10.11622/smedj.2021059 · Cited by 11
Velten, J., Christiansen, H., Hoyer, J., In‐Albon, T., Lincoln, T. M., Lutz, W., Margraf, J., Schöttke, H., Stark, R. M., Werheid, K., et al. (2025) · Behaviour Research and Therapy · doi:10.1016/j.brat.2025.104691 · Cited by 14
Hijne, K., van der Sluijs, J. F. V. E., Kloth, S. A. M., Lucassen, P. L., Reinders, M., Tak, L. M., Gerritsen, L., & Geenen, R. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110712 · Cited by 9
“Cognitive behavioral therapy has been proposed as best-established treatment for somatoform disorder, the precursor diagnostic category of SSD [2].”
BackgroundLee, T., Li, C. R., & Tramontano, G. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.166 · Cited by 10
Somatoform disorders in patients with chronic subjective tinnitus
Şahin, C., Aras, H. İ., & Yılmaz, M. S. (2016) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-016-3968-7 · Cited by 9
Stieler, M., Pockney, P. G., Campbell, C., Thirugnanasundralingam, V., Gan, L., Spittal, M. J., & Carter, G. L. (2022) · BJS Open · doi:10.1093/bjsopen/zrac046 · Cited by 9
Mundt, A. P., Ströhle, A., Heimann, H., Heinz, A., & Grohmann, R. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1976 · Cited by 9
“More than three quarters of the patients received antidepressant agents, although empirical evidence is still scarce.(12) Close to one half of the patients received off-label neuroleptic treatment although there is hardly any evidence from trials.”
BackgroundSomatoform Disorder: Treatment Utilization and Cost by Mental Health Professions
Crane, D. R., Morton, L. B., Fawcett, D., Moore, A., Larson, J. H., & Sandberg, J. G. (2012) · Contemporary Family Therapy · doi:10.1007/s10591-012-9182-x · Cited by 9
“Several studies have tested the treatment outcomes of psychotherapy treatment modalities such as cognitive behavioral and psychodynamic therapies (Allen et al. 2006; Harvard Mental Health Letter 2009; Kraft et al. 2006; Kroenke 2007; Kroenke and Swindle 2000; Sumathipala 2007; Tazaki and Landlaw 2006).”
BackgroundShapiro, M. A., Bussing, R., & Nguyen, M. L. (2014) · Pragmatic Case Studies in Psychotherapy · doi:10.14713/pcsp.v10i4.1873 · Cited by 7
“CBT has been shown to be the most validated treatment for anxiety disorders in children and adolescents (AACAP Practice Parameter, 2007), and has been shown to be effective for somatoform disorders (Kroenke, 2007).”
BackgroundDimensional Psychopharmacology in Somatising Patients
Biondi, M., & Pasquini, M. (2015) · Advances in psychosomatic medicine · doi:10.1159/000369082 · Cited by 8
Hypochondriasis and Somatization Disorder: New Perspectives
Lipsitt, D. R. (2014) · Springer eBooks · doi:10.1007/978-3-319-11005-9_23 · Cited by 11
[Towards a unified treatment approach for functional somatic syndromes and somatization].
Schröder, A., Fink, P., Fjordback, L., Frostholm, L., & Rosendal, M. (2010) · PubMed · Cited by 11
Somatoforme Störungen – somatoforme Belastungsstörung und verwandte Störungen
Kapfhammer, H. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_74 · Cited by 14
Psychotherapy and the Professional Identity of Psychiatry in the Age of Neuroscience
Belcher, R. (2019) · Academic Psychiatry · doi:10.1007/s40596-019-01123-w · Cited by 8
Somatic Presentations—A Challenge for DSM-V
Dimsdale, J. E., Patel, V., Yu, X., & Kleinman, A. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31815b005d · Cited by 8
Lewis, H. (2013) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x13000202 · Cited by 8
“Several reviews demonstrate significant evidence for the use of cognitive behavioural therapy (CBT) for people with medically unexplained symptoms (MUS) (Nezu et al. 2001; Kroenke, 2007; Allen & Woolfolk, 2010).”
BackgroundDhanji, S. R., & Lawlor, M. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000423 · Cited by 8
Cognitive rehabilitation treatment for mental slowness in conversion disorder: A case report
de Vroege, L., Khasho, D., Foruz, A., & Feltz-Cornelis, C. M. V. D. (2017) · Cogent Psychology · doi:10.1080/23311908.2017.1348328 · Cited by 12
“This opens an alternative avenue for treatment of CD that may be very welcome, especially because few successful treatment options are known for CD (Kroenke, 2007).”
BackgroundResearch on Somatization and Somatic Symptom Disorders: Ars longa, vita brevis
Dimsdale, J. E. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000533 · Cited by 8
Somatization in childhood and adolescence: a guide to facilitate its understanding
Díez‐Suárez, A., & Hernández-González, C. (2025) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2025.503711 · Cited by 13
Somatoform disorders in patients with chronic pain
Mohan, I., Lawson-Smith, C., Coall, D. A., van der Watt, G., & Janča, A. (2013) · Australasian Psychiatry · doi:10.1177/1039856213511675 · Cited by 10
Somatic Symptom Disorder: Costly, Stressful for Patients and Providers, and Potentially Lethal
Davison, W. L., & Simberlund, J. (2016) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2016.110805 · Cited by 7
Identification, assessment and treatment of individual patients
Creed, F. H., Feltz-Cornelis, C. M. V. D., Guthrie, E., Henningsen, P., Rief, W., Schröder, A., & White, P. D. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977862.009 · Cited by 10
Somatization: the under-recognized factor in nonspecific eczema. The Hordaland Health Study (HUSK)
Klokk, M., Stansfeld, S. A., Øverland, S. N., Wilhelmsen, I., Götestam, K. G., Steinshamn, S., & Mykletun, A. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10150.x · Cited by 8
Understanding Consequences of Mental–Physical Comorbidity
Korff, M. R. V. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511770531.021 · Cited by 7
Williams, P., Smith, T. W., & Jordan, K. D. (2010) · American Psychological Association eBooks · doi:10.1037/12084-010 · Cited by 8
Stephen, C. D., Sharma, N., Callahan, J., Carson, A. J., & Perez, D. L. (2017) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000135 · Cited by 7
“Carson, MB ChB, MPhil, MD, FRCPsych, FRCP Cognitive-behavioral therapy is said to be the treatment of choice for functional neurological disorders,(28,66) but this claim largely rests on CBT’s successful use in somatoform disorders in general.(67,68) However, while FND and somatoform disorders share risk factors, it i…”
BackgroundPapadopoulos, N. L. R., & Röhricht, F. (2018) · The Arts in Psychotherapy · doi:10.1016/j.aip.2018.09.001 · Cited by 13
Somatic Symptom and Related Disorders
Williams, S. E., Zahka, N. E., & Kullgren, K. A. (2020) · Issues in clinical child psychology · doi:10.1007/978-3-030-35598-2_14 · Cited by 7
Beutel, M. E., von Heymann, F., Bleichner, F., Tritt, K., & Hardt, J. (2014) · Zeitschrift für psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2014.60.1.17 · Cited by 7
Somatization in acute care pediatrics: Respecting the mind–body connection
Jenkins, W., & Smart, K. (2020) · Clinical Child Psychology and Psychiatry · doi:10.1177/1359104520905065 · Cited by 8
“In general, cognitive behavioral therapy is the recommended therapeutic approach (Kroenke, 2007).”
BackgroundRadziej, K., Schmid-Mühlbauer, G., Limburg, K., & Lahmann, C. (2017) · PPmP Psychotherapie Psychosomatik Medizinische Psychologie · doi:10.1055/s-0043-104768 · Cited by 6
“für die kognitive Verhaltenstherapie vor [15].”
Fang, J., Tang, H., Liao, H., Zhong, Y., Li, Y., Liao, Y., & Li, Y. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s512848 · Cited by 6
Yap, A. U., Kim, S. H., Jo, J. H., Lee, B.-M., & Park, J. W. (2024) · Journal of Oral Rehabilitation · doi:10.1111/joor.13857 · Cited by 7
Shared mental healthcare and somatization: changes in patient symptoms and disability
Haggarty, J. M., O’Connor, B. P., Mozzon, J. B., & Bailey, S. K. (2015) · Primary Health Care Research & Development · doi:10.1017/s1463423615000420 · Cited by 6
“The author concluded that CBT was the ‘best established treatment’ (Kroenke, 2007: 414).”
BackgroundResultInfluentialStieler, M., Pockney, P. G., Campbell, C., Thirugnanasundralingam, V., Gan, L., Spittal, M. J., & Carter, G. L. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674211044639 · Cited by 7
“Systematic reviews have identified effective treatments for somatoform disorders with improved patient outcomes and reduced health service costs (Kroenke, 2007).”
BackgroundBrexpiprazole as a new approach of treatment in somatization disorder
Chiappini, S., Mosca, A., Martinotti, G., Carlo, F. D., Miuli, A., Dattoli, L., Pettorruso, M., & Giannantonio, M. D. (2022) · Emerging Trends in Drugs Addictions and Health · doi:10.1016/j.etdah.2022.100031 · Cited by 6
“…of SD As for the treatment, while cognitive behaviour therapy (CBT) nd mindfulness-based therapy have given good results ( Tyrer et al., 014 ; Kroenke, 2007 ; Williams and Kuyken, 2012 ; O’Malley et al., 999 ), somatization disorders can be refractory to psychiatric interention including…”
MethodRobbins-Welty, G. A., Shalev, D., Riordan, P. A., Noufi, P. E., Webb, J. A., Brenner, K. O., Rosa, W. E., & Chammas, D. (2024) · Journal of Palliative Medicine · doi:10.1089/jpm.2024.0131 · Cited by 9
Haas, L., Stargardt, T., Schreyögg, J., Schlösser, R., Klapp, B. F., & Danzer, G. (2013) · Applied Health Economics and Health Policy · doi:10.1007/s40258-013-0042-0 · Cited by 6
The outcome of medically unexplained symptoms—Will DSM-V improve on DSM-IV somatoform disorders?
Creed, F. H. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.10.022 · Cited by 8
“Sound evidence that the symptoms described as medically unexplained and related disorders can be satisfactorily treated is gradually accumulating [19].”
BackgroundSatisfaction and Occupational Performance in Patients with Functional Movement Disorder
Dahlhauser, S. E., Theuer, A. B., & Hollman, J. H. (2017) · The Open Journal of Occupational Therapy · doi:10.15453/2168-6408.1287 · Cited by 6
“hypnosis, acupuncture, electromyography biofeedback, and placebo (Ellenstein, Kranick, & Hallett, 2011; Kroenke, 2007; Reich, 2006).”
Psychological Treatment of Functional Movement Disorder
Mack, J., & LaFrance, W. C., Jr. (2022) · Current clinical neurology · doi:10.1007/978-3-030-86495-8_21 · Cited by 7
Gabapentin in Somatoform and Panic Disorder
Joos, A. A. B., & Zeeck, A. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000426187.42045.a3 · Cited by 8
Ajluni, V. (2024) · Journal of General and Family Medicine · doi:10.1002/jgf2.725 · Cited by 7
Trastorno conversivo en niños y adolescentes
Duque, P. A., Vásquez, R., & Cote, M. (2015) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2015.06.004 · Cited by 9
Blawath, S., Metten, R., & Tschuschke, V. (2014) · Zeitschrift für psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2014.60.4.337 · Cited by 6
Feltz-Cornelis, C. M. V. D., Brabyn, S., Allen, S. F., Reilly, J. G., Clarke, C., de Vroege, L., Gilbody, S. M., Wittington, M., & Lagos, D. (2020) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2020.04.002 · Cited by 5
Nicholson, T. R., & Kanaan, R. (2009) · Psychiatry · doi:10.1016/j.mppsy.2009.03.001 · Cited by 5
Kendall, E. A., Zaman, R. U., Naved, R. T., Rahman, M. W., Kadir, M., Arman, S., Azziz‐Baumgartner, E., & Gurley, E. S. (2012) · BMC Women s Health · doi:10.1186/1472-6874-12-38 · Cited by 5
“Patients' symptoms are difficult for clinicians to understand; [12] a suspicion that patients are feigning often leads to patient-provider conflict; [12,13] associated health care utilization and costs are high; [14] and treatment, although often possible, requires time and close patient-provider cooperation [13,15].”
van Driel, D. T. J. W., Hanssen, D. J. C., Hilderink, P. H., Naarding, P., Lucassen, P. L., Rosmalen, J. G. M., & Voshaar, R. C. O. (2016) · Psychological Assessment · doi:10.1037/pas0000303 · Cited by 6
Open Trial of Integrated Primary Care Consultation for Medically Unexplained Symptoms
Hubley, S. H., Uebelacker, L. A., Nash, J. M., & Eaton, C. B. (2016) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-016-9528-5 · Cited by 5
12 Cognitieve therapie bij hypochondrie en andere somatoforme stoornissen
Visser, S., & Reinders, M. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8310-8_12 · Cited by 6
Lok, A., Assies, J., Koeter, M. W. J., Bockting, C., Wouters, L. F., Mocking, R. J. T., & Schene, A. H. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.024 · Cited by 5
From Photography to fMRI: Epistemic Functions of Images in Medical Research on Hysteria
Muhr, P. (2022) · transcript Verlag eBooks · doi:10.14361/9783839461761 · Cited by 13
Psychological Models of Tinnitus
Dauman, N., Hobeika, L., Erlandsson, S., Cima, R. F. F., McKenna, L., Samson, S., & Londero, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-35647-6_21 · Cited by 4
Cruz, C., Chudleigh, C., Savage, B., & Kozlowska, K. (2014) · Australian and New Zealand Journal of Family Therapy · doi:10.1002/anzf.1059 · Cited by 6
“Individual therapy with the patient includes cognitive behavioural therapy, integrated with mind-body techniques to assist in the child developing awareness of their internal body states and emotions (Church, De Asis & Brooks, 2012; Church, Pina, Reategui & Brooks, 2012; Kozlowska et al., 2012a, 2013a; Kroenke, 2007).”
MethodCognitive-behavioural skills training for medical students: development and evaluation
Kearley, K. E., & Croft, A. J. (2010) · The Psychiatrist · doi:10.1192/pb.bp.108.023994 · Cited by 4
Neurotic, stress-related and somatoform disorders
Sharpe, M., Baldwin, D. S., & Walker, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-3137-3.00017-6 · Cited by 8
Medically unexplained physical symptoms: Evidence-based interventions
Huang, H., & McCarron, R. M. (2011) · Current psychiatry · Cited by 4
Somatik Belirti Bozukluğu: Tarihsel Süreç ve Biyopsikososyal Yaklaşım
Çetin, Ş., & Varma, G. S. (2021) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.882929 · Cited by 15
Management of Somatization in COVID-19: A Narrative Review
Wankhade, D., & Anjankar, A. P. (2022) · Cureus · doi:10.7759/cureus.30262 · Cited by 4
“The most effective treatment for a number of somatoform disorders is cognitive behavioural therapy (CBT), while studies have also shown some benefits of consulting a primary care provider [24].”
BackgroundDoes gender matter? Exploring mental health recovery court legal and health outcomes
Kothari, C., Butkiewicz, R., Williams, E., Jacobson, C., Morse, D. S., & Cerulli, C. (2014) · Health & Justice · doi:10.1186/s40352-014-0012-0 · Cited by 7
Neuroimaging Studies of Somatoform Pain Disorder: How Far Have We Come?
Yoshino, A., Okamoto, Y., & Yamawaki, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-48046-6_12 · Cited by 4
Multiple Myeloma, Misdiagnosed As Somatic Symptom Disorder: A Case Report
Yao, J., Lv, D., & Chen, W. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00557 · Cited by 6
Upper extremity conversion disorder in children
Murgai, R. R., Vandenberg, C. D., Stevanovic, M. V., & Lightdale-Miric, N. R. (2019) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2018.10.027 · Cited by 4
López-García-Franco, A., del-Cura-González, M. I., Caballero-Martínez, L., Sanz‐Cuesta, T., Díaz-García, M., Rodríguez-Monje, M. T., Chahua, M., Muñoz-Sanchez, I., Serrano-González, D., Rollán-Llanderas, T., et al. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-35 · Cited by 4
“In a recent systematic review of the 34 analyzed RCTs on interventions in somatoform symptoms, only 9 are developed in primary care [12].”
BackgroundWilliams, D. T., & Harding, K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374105-9.00316-6 · Cited by 4
Gabapentin as Add-On Treatment for Somatoform Disorder
Guglielmo, R., Martinotti, G., & Janiri, L. (2012) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31823e669b · Cited by 3
“Somatoform disorders are among the most prevalent mental disorders seen in the general medical setting, present in 10% to 15% of primary care patients.(1) There are few systematic studies on psychopharmacology treatment of somatoform disorders.”
BackgroundAl-Balushi, M. S., & A-Jadidi, S. (2023) · Journal of Case Reports · doi:10.17659/01.2023.0018 · Cited by 3
Psychological Disorders Are a Non-negligible Factor in Medical Aesthetic Disputes
Yan, C., Wen, R., Chen, N., Fan, Y., Li, J., Peng, Y., Li, X., Xu, X., Jia, C., & Wang, Y. (2025) · Aesthetic Plastic Surgery · doi:10.1007/s00266-025-04940-7 · Cited by 6
강지연, & Eunsun, J. (2014) · The Korean Journal of Woman Psychology · doi:10.18205/kpa.2014.19.1.002 · Cited by 3
Izadi, F., Ashrafi, E., & Fathi-Ashtiani, A. (2019) · Journal of Research in Behavioural Sciences · doi:10.52547/rbs.17.2.232 · Cited by 6
Uijen, A. A., & Bischoff, E. W. M. A. (2011) · Huisarts en Wetenschap · doi:10.1007/s12445-011-0267-9 · Cited by 3
Crapanzano, C., Amendola, C., Politano, A., Laurenzi, P. F., & Casolaro, I. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001052 · Cited by 5
Hypochondriasis or Health Anxiety ☆
Wilhelmsen, I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.06457-9 · Cited by 3
Harding, K. J. K., Skritskaya, N. A., Doherty, E. R., & Fallon, B. A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.012 · Cited by 3
Psychological Co-morbidities in Patients with Pain
Dorsten, B. V., & Weisberg, J. N. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0029-6_7 · Cited by 5
Inamura, K., Shinagawa, S., Nagata, T., Tagai, K., Nukariya, K., & Nakayama, K. (2016) · Psychosomatics · doi:10.1016/j.psym.2016.02.006 · Cited by 4
Caring for Patients With Functional Neurological Disorders: A Case-oriented Review
O’Neal, M. A., & Dworetzky, B. A. (2016) · The Neurologist · doi:10.1097/nrl.0000000000000078 · Cited by 3
Прибытков, А. А. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20161165152-56 · Cited by 3
Polypharmacy in Psychiatry Practice, Volume II: Use of Polypharmacy in the "Real World"
Ritsner, M. S. (2013) · Springer eBooks · doi:10.1007/978-94-007-5799-8 · Cited by 5
Somatization disorder and related disorders
Fink, P. (2012) · doi:10.1093/med/9780199696758.003.0129 · Cited by 3
Somatic Symptom and Related Disorders
Holster, J. L., Hawks, E. M., & Ostermeyer, B. K. (2017) · Psychiatric Annals · doi:10.3928/00485713-20170308-03 · Cited by 3
Psychopathology and Classification
Eldar, S., Gómez, A. F., & Hofmann, S. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-56194-3_1 · Cited by 3
From DSM-Ⅳ Somatoform Disorder to DSM-5 Somatic Symptom Disorder
Zichen, C. H. E. N., & Wang, X. (2013) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2013.01967 · Cited by 3
Applying Ontological Realism to Medically Unexplained Syndromes
Doing-Harris, K. M., Meystre, S. M., Samore, M. H., & Ceusters, W. M. (2013) · Studies in health technology and informatics · doi:10.3233/978-1-61499-289-9-97 · Cited by 3
Kapfhammer, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_61 · Cited by 3
Cognitive Behavioral Therapy for Somatoform Disorders
Robert, L., & Lesley, A. (2012) · InTech eBooks · doi:10.5772/26800 · Cited by 3
Langfitt, J. T., & Watson, W. (2010) · Neurology · doi:10.1212/wnl.0b013e3182015290 · Cited by 3
Hypochondriasis or Health Anxiety
Wilhelmsen, I. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375000-6.00197-x · Cited by 4
Fors, E. A., Stiles, T. C., & Borchgrevink, P. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375000-6.00340-2 · Cited by 4
Metadata
- Authors
- Kroenke, K.
- Affiliations
- Regenstrief Institute (US)
- Corresponding author
- Kroenke, Kurt
- ORCID
- Kroenke, Kurt
- Venue
- Psychosomatic Medicine
- Published
- 2007-11
- Volume
- 69
- Issue
- 9
- Pages
- 881-888
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2004606740
- Cited by
- 450
- References
- 68
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 10 · 2023: 4 · 2022: 13 · 2021: 14 · 2020: 16 · 2019: 20 · 2018: 25 · 2017: 39 · 2016: 26 · 2015: 22 · 2014: 40 · 2013: 48 · 2012: 41
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- somatoform disorders, somatization disorder, medically unexplained symptoms, health anxiety, conversion disorder, pain disorders, body dysmorphic disorder, cognitive behavioral therapy, antidepressants, treatment efficacy
- MeSH terms
- Antidepressive Agents, Body Image, Combined Modality Therapy, Conversion Disorder, Delusions, Hypochondriasis, Primary Health Care, Somatoform Disorders, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.